WallStreetZenWallStreetZen

NASDAQ: ELYM
Eliem Therapeutics Inc Stock

$3.85+0.00 (+0%)
Updated Jan 27, 2023
ELYM Price
$3.85
Fair Value Price
N/A
Market Cap
$102.29M
52 Week Low
$2.36
52 Week High
$11.51
P/E
-21.39x
P/B
0.76x
P/S
N/A
PEG
N/A
Dividend Yield
N/A
Revenue
$0.00
Earnings
-$48.03M
Gross Margin
N/A
Operating Margin
N/A
Profit Margin
N/A
Debt to Equity
0.05
Operating Cash Flow
-$37M
Beta
0.61
Next Earnings
Mar 6, 2023
Ex-Dividend
N/A
Next Dividend
N/A

ELYM Overview

Eliem Therapeutics, Inc., a clinical-stage biotechnology company, develops therapies to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other for neuronal excitability disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 and ETX-155. The company also develops preclinical pipeline programs, such as the Kv7 Program and Anxiolytic. Eliem Therapeutics was incorporated in 2018 and is headquartered in Redmond, WA.

Zen Score

Industry Average (28)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how ELYM scored across 33 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

ELYM is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
ELYM is good value based on its book value relative to its share price (0.76x), compared to the US Biotechnology industry average (5.18x)
P/B vs Industry Valuation
ELYM is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 30 more ELYM due diligence checks available for Premium users.

Be the first to know about important ELYM news, forecast changes, insider trades & much more!

ELYM News

Valuation

ELYM fair value

Fair Value of ELYM stock based on Discounted Cash Flow (DCF)
Price
$3.85
Fair Value
$5.65
Undervalued by
31.92%
ELYM is unprofitable, so we... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

ELYM price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-21.39x
Industry
12.89x
Market
23.59x

ELYM price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
0.76x
Industry
5.18x
ELYM is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

ELYM's financial health

Profit margin

Revenue
$0.0
Net Income
-$9.7M
Profit Margin
0%
ELYM's cash and short-term investments... subscribe to Premium to read more.
Interest Coverage Financials

Assets to liabilities

Assets
$140.9M
Liabilities
$6.5M
Debt to equity
0.05
ELYM's short-term assets ($133.17M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
ELYM's short-term assets ($133.17M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
ELYM's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
-$4.2M
Investing
$8.5M
Financing
$0.0
ELYM's cash and short-term investments... subscribe to Premium to read more.
Debt Coverage Financials

ELYM vs Biotech Stocks

TickerMarket Cap1d %P/EP/B
ELYM$102.29M0.00%-21.39x0.76x
FBIO$101.12M+4.61%-0.36x1.64x
VTVT$103.53M+1.43%-3.30x-6.25x
ATOS$103.83M+0.99%-4.32x0.84x
OPNT$104.70M-0.10%-3.11x5.11x

Eliem Therapeutics Stock FAQ

What is Eliem Therapeutics's quote symbol?

NASDAQ: ELYM) Eliem Therapeutics trades on the NASDAQ under the ticker symbol ELYM. Eliem Therapeutics stock quotes can also be displayed as NASDAQ: ELYM.

If you're new to stock investing, here's how to buy Eliem Therapeutics stock.

What is the 52 week high and low for Eliem Therapeutics (NASDAQ: ELYM)?

(NASDAQ: ELYM) Eliem Therapeutics's 52-week high was $11.51, and its 52-week low was $2.36. It is currently -66.54% from its 52-week high and 63.14% from its 52-week low.

How much is Eliem Therapeutics stock worth today?

(NASDAQ: ELYM) Eliem Therapeutics currently has 26,567,681 outstanding shares. With Eliem Therapeutics stock trading at $3.85 per share, the total value of Eliem Therapeutics stock (market capitalization) is $102.29M.

Eliem Therapeutics stock was originally listed at a price of $15.90 in Aug 10, 2021. If you had invested in Eliem Therapeutics stock at $15.90, your return over the last 1 years would have been -75.79%, for an annualized return of -75.79% (not including any dividends or dividend reinvestments).

How much is Eliem Therapeutics's stock price per share?

(NASDAQ: ELYM) Eliem Therapeutics stock price per share is $3.85 today (as of Jan 27, 2023).

What is Eliem Therapeutics's Market Cap?

(NASDAQ: ELYM) Eliem Therapeutics's market cap is $102.29M, as of Jan 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Eliem Therapeutics's market cap is calculated by multiplying ELYM's current stock price of $3.85 by ELYM's total outstanding shares of 26,567,681.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.